Print

Purpose

The goal of this study is to test an electronic health (eHealth) mindfulness-based music therapy intervention to improve health-related quality of life and reduce symptom burden and disease activity in patients undergoing stem cell transplantation.

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • ≥ 18 years of age - have a primary diagnosis of a hematologic malignancy (e.g., myelodysplastic syndrome [MDS], acute myeloid leukemia [AML], acute lymphoblastic leukemia [ALL], or non Hodgkin's Lymphoma [NHL]) - have a treatment plan for a hematopoietic stem cell transplant - Speak English or Spanish

Exclusion Criteria

  • history of severe psychiatric illness (e.g., psychosis, active suicidality, inpatient treatment in the past 12 months) - severe cognitive impairment (per the short portable mental status questionnaire) - hearing impairment - active alcohol or substance dependence within the past six months - participated in the prior pilot MBMT R61 phase - participated in music therapy or mindfulness programs in the past six months

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Supportive Care
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
eHealth Mindfulness-based Music Therapy (eMBMT) 		Participants will be in the MBMT group for 5 months.
  • Behavioral: eHealth Mindfulness-based Music Therapy (eMBMT)
    Participants will receive 8 music therapy sessions that will last approximately 60 minutes in length. A Music therapist will conduct the sessions. These sessions will be in person and/or virtual depending on patient status and the time between sessions will vary based on patient response to treatment.
Experimental
eHealth Mindfulness Meditation (eMM) 		Participants will be in the MM group for 5 months.
  • Behavioral: eHealth Mindfulness Meditation (eMM)
    Participants will receive 8 mindfulness meditation sessions that will last approximately 60 minutes in length. These sessions will be participant led virtually.

Recruiting Locations

University of Miami
Miami, Florida 33136
Contact:
Tea Kostreni
305-243-4445
txk706@med.miami.edu

More Details

Status
Recruiting
Sponsor
University of Miami

Study Contact

Frank J Penedo, PhD
(305) 284-4290
fpenedo@miami.edu

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.